Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
128 hedge funds and large institutions have $1.2B invested in Immunogen Inc in 2013 Q2 according to their latest regulatory filings, with 128 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
78% more call options, than puts
Call options by funds: $10.4M | Put options by funds: $5.82M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
126
M&T Bank
Buffalo,
New York
| $2K | +$1.62K | +100 | New |
|
|
MBT
127
Monroe Bank & Trust
Monroe,
Michigan
| $2K | +$2.35K | +145 | New |
|
|
MFS
128
MSI Financial Services
Springfield,
Massachusetts
| $1K | +$1.22K | +75 | New |
|
IMGN Hedge Fund Activity: Q2 2013 in Review
128 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2013, worth a combined $1.2B.
Buyers outnumbered sellers: 128 funds opened new IMGN positions and 0 closed out — a net gain of 128 holders — while 0 added to existing stakes and 0 trimmed.
- 128 institutional investors held Immunogen Inc (IMGN) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $1.2B of Immunogen Inc stock for Q2 2013.
- 128 funds opened new Immunogen Inc positions in Q2 2013 and 0 closed out, a net change of +128 holders.
Based on aggregated 13F filings for Q2 2013.